Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Screening based on risk for colorectal cancer is the most cost-effective approach.

Dan YY, Chuah BY, Koh DC, Yeoh KG.

Clin Gastroenterol Hepatol. 2012 Mar;10(3):266-71.e1-6. doi: 10.1016/j.cgh.2011.11.011.

PMID:
22100624
2.

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.

Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013.

PMID:
23542330
3.

Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F, Inadomi JM.

Ann Intern Med. 2000 Oct 17;133(8):573-84.

PMID:
11033584
4.

Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.

Sharaf RN, Ladabaum U.

Am J Gastroenterol. 2013 Jan;108(1):120-32. doi: 10.1038/ajg.2012.380.

PMID:
23247579
5.

Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.

Tsoi KK, Ng SS, Leung MC, Sung JJ.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):353-63. doi: 10.1111/j.1365-2036.2008.03726.x.

6.

Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.

Song K, Fendrick AM, Ladabaum U.

Gastroenterology. 2004 May;126(5):1270-9.

PMID:
15131787
7.

Cost effectiveness and projected national impact of colorectal cancer screening in France.

Hassan C, Benamouzig R, Spada C, Ponchon T, Zullo A, Saurin JC, Costamagna G.

Endoscopy. 2011 Sep;43(9):780-93. doi: 10.1055/s-0030-1256409.

PMID:
21623557
8.

Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.

Hassan C, Rex DK, Cooper GS, Zullo A, Launois R, Benamouzig R.

Gut. 2012 Aug;61(8):1172-9. doi: 10.1136/gutjnl-2011-300206.

PMID:
21997545
9.

Cost-effectiveness of screening for colorectal cancer in the general population.

Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

JAMA. 2000 Oct 18;284(15):1954-61.

PMID:
11035892
10.

The economic evaluation of screening for colorectal cancer: Case of Iran.

Barouni M, Ghaderi H, Shahmoradi MK.

Clin Lab. 2013;59(5-6):667-74.

PMID:
23865368
11.

Colorectal cancer screening for average-risk North Americans: an economic evaluation.

Heitman SJ, Hilsden RJ, Au F, Dowden S, Manns BJ.

PLoS Med. 2010 Nov 23;7(11):e1000370. doi: 10.1371/journal.pmed.1000370. Erratum in: PLoS Med. 2012 Nov;9(11). doi: 10.1371/annotation/0fd49c83-2c6d-42b5-a8c1-45a0aaedaa77.

12.

[Cost-effectiveness of colorectal cancer screening].

Heresbach D, Manfrédi S, Branger B, Bretagne JF.

Gastroenterol Clin Biol. 2006 Jan;30(1):44-58. French.

13.
14.

Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.

Lucidarme O, Cadi M, Berger G, Taieb J, Poynard T, Grenier P, Beresniak A.

Eur J Radiol. 2012 Jul;81(7):1413-9. doi: 10.1016/j.ejrad.2011.03.027.

PMID:
21444171
15.

Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.

Vijan S, Hwang EW, Hofer TP, Hayward RA.

Am J Med. 2001 Dec 1;111(8):593-601.

PMID:
11755501
16.

Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.

Hassan C, Zullo A, Winn S, Morini S.

Endoscopy. 2008 May;40(5):414-21. doi: 10.1055/s-2007-995565.

PMID:
18302080
17.

Cost-effectiveness of a single colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F.

Arch Intern Med. 2002 Jan 28;162(2):163-8.

PMID:
11802749
18.

Cost-effectiveness of family history-based colorectal cancer screening in Australia.

Ouakrim DA, Boussioutas A, Lockett T, Hopper JL, Jenkins MA.

BMC Cancer. 2014 Apr 16;14:261. doi: 10.1186/1471-2407-14-261.

19.

Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis.

Hassan C, Rex DK, Cooper GS, Benamouzig R.

Endoscopy. 2012 May;44(5):456-64. doi: 10.1055/s-0032-1308936.

PMID:
22531982
20.

Cost-effectiveness analysis of colorectal cancer screening methods in Iran.

Allameh Z, Davari M, Emami MH.

Arch Iran Med. 2011 Mar;14(2):110-4. doi: 011142/AIM.008.

Supplemental Content

Support Center